跳至主要内容
临床试验/CTRI/2022/04/041779
CTRI/2022/04/041779尚未招募未知

Assessment of the early heterologous effect of two BCG strains given at birth in preterm neonates born at 30-35 weeks of gestation: An immunological exploratory study

Department of Paediatrics0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Neonates born at 30-35 weeks of gestation and admitted in NICU
  • 2. Informed written consent obtained from parents

排除标准

  • 1. Neonates born to mothers with:
  • a. HIV, HBV or tuberculosis infection or receiving immunosuppressive medications
  • b. Suspected triple-I (fever without a clear source with either baseline fetal tachycardia/maternal TLC >15000/mcl AND/OR definite purulent fluid from cervical os) or prolonged rupture of membranes >18 hours
  • c. History of early neonatal death/family history of immunodeficiency
  • 2. Neonates with severe birth asphyxia
  • 3. Neonates with major congenital malformations
  • 4. Parents who refuse to give informed consent/withdraw consent

研究者

相似试验